My ePortfolio Register   

Tailoring treatment strategies in prostate cancer: expert insight

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.09.15
Views: 3072
Rating:

Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu

Prof Efstathiou (MD Anderson Cancer Center, Houston, USA) chairs a discussion for ecancertv at ECC 2015 with Dr De Santis (University of Warwick, Coventry, UK) and Dr Tunariu (Royal Marsden Hospital, London, UK) about advances in prostate cancer, including chemoprevention and imaging.

In particular, they discuss the ways in which different patient subgroups react to treatments.

Dr De Santis argues that chemotherapy with docetaxel is beneficial for all patients with metastatic disease, including those who are hormone-sensitive, and Dr Tunariu argues the need to better utilise imaging for more personalised and thus more effective treatment strategies.

They also consider the directions that treatment may go in, 5 years from now.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence